Genome editing for neurodegenerative diseases : from concept to clinical trials /
Genome Editing for Neurodegenerative Diseases: From Concept to Clinical Trials examines recent advances in neurodegenerative disease research and clinical challenges in practical applications. With an emphasis on genome editing tools such as ZFNs, TALENSs and CRISPR-Cas, this book sheds light on the...
| Corporate Author: | |
|---|---|
| Other Authors: | , , , |
| Format: | eBook |
| Language: | English |
| Published: |
London, United Kingdom ; San Diego, CA, United States ; Cambridge, MA, United States :
Elsevier, Academic Press, an Imprint of Elsevier,
[2025]
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | Genome Editing for Neurodegenerative Diseases: From Concept to Clinical Trials examines recent advances in neurodegenerative disease research and clinical challenges in practical applications. With an emphasis on genome editing tools such as ZFNs, TALENSs and CRISPR-Cas, this book sheds light on the possibilities to counteract genetic and neurodegenerative diseases. It will be of interest to researchers in neuroscience and biopharmaceuticals, as well as clinicians specializing in neurodegenerative diseases. |
|---|---|
| Physical Description: | 1 online resource (xx, 240 pages) : color illustrations |
| Bibliography: | Includes bibliographical references and index. |
| ISBN: | 9780443238277 0443238278 |